healthcarebuddyのブログ

Healthcarebuddy blog is related to all healthcare topics.

Microfluidic Devices Market Size Report 2021

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities) and Others) and Regional Forecast, 2019-2026, ”the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098


However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years ..


Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:


UFluidix
Perkin Elmer
Fluidigm
Blacktrace Holdings Ltd. (Dolomite Microfluidic)
Micronit
BioFluidix GmbH
Fluigent
ALine, Inc.
Philips
Other Prominent Players
from Schott AG Acquires MINIFAB To Develop Top-Quality Polymer And Glass Solutions


Schott AG, a company specializing in the production of glass and glass-ceramics, based in Germany, declared that it has completed its acquisition of MINIFAB PTY Ltd., a provider of custom-designed and manufactured microfluidic and medical devices, based in Australia in June 2019. This strategic collaboration will enable both companies to upgrade their portfolios in the diagnostics market. They will be able to provide the products to their existing consumers as well as serve new consumers effectively in the upcoming years by developing centers of excellence for glass in Germany and polymer in Australia.